Literature DB >> 25434351

Electrophysiological characteristics of permanent atrial fibrillation: insights from research models of cardiac remodeling.

Andreu M Climent1, Maria S Guillem, Felipe Atienza, Francisco Fernández-Avilés.   

Abstract

Atrial fibrillation (AF) results in a remodeling of the electrical and structural characteristics of the cardiac tissue which dramatically reduces the efficacy of pharmacological and catheter-based ablation therapies. Recent experimental and clinical results have demonstrated that the complexity of the fibrillatory process significantly differs in paroxysmal versus persistent AF; however, the lack of appropriate research models of remodeled atrial tissue precludes the elucidation of the underlying AF mechanisms and the identification of appropriated therapeutic targets. Here, we summarize the different research models used to date, highlighting the lessons learned from them and pointing to the new doors that should be open for the development of innovative treatments for AF.

Entities:  

Keywords:  atrial fibrillation; electrophysiological properties; persistent AF; rotors; tissue remodeling

Mesh:

Year:  2014        PMID: 25434351     DOI: 10.1586/14779072.2015.986465

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  2 in total

1.  Transcatheter closure of atrial septal defects improves cardiac remodeling and function of adult patients with permanent atrial fibrillation.

Authors:  Liang Chen; Yuan Bai; Fei-Yu Wang; Zhi-Gang Zhang; Xing-Hua Shan; Tao Chen; Xian-Xian Zhao; Yong-Wen Qin
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

2.  Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico intersubject variability study.

Authors:  Alejandro Liberos; Alfonso Bueno-Orovio; Miguel Rodrigo; Ursula Ravens; Ismael Hernandez-Romero; Francisco Fernandez-Aviles; Maria S Guillem; Blanca Rodriguez; Andreu M Climent
Journal:  Heart Rhythm       Date:  2016-08-26       Impact factor: 6.343

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.